Tokyo Tape
Sign in
← Nipro

Quarterly report · Q3

8086.TEDINET S100Q5DE
Period2022-04-01 → 2022-12-31
Filed2023-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥406.3bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥494.8bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥369.4bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥13.2bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥19.7bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥13.8bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥27.6bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥20.6bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥14.7bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥19.1bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥7.0bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥13.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥11.0bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥8.1bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥12.2bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥1.05Tat 2022-12-31Cons.Assets
Total assets¥930.3bnat 2022-03-31Cons.Assets
Total assets¥902.8bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥809.0bnat 2022-12-31Cons.Liabilities
Total liabilities¥730.5bnat 2022-03-31Cons.Liabilities
Net assets / equity¥240.2bnat 2022-12-31Cons.Net assets
Net assets / equity¥199.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥193.7bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥102.7bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥95.3bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥42.692022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥4.352022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥82.52021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥67.682021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥22.92021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥37.822022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥77.422021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥64.772021-04-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio21.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio19.9%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio19.9%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥3.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥530m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥166m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥28.6bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥28.6bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥22.5bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue2022-04-01 → 2022-12-31¥318.8bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue external2022-04-01 → 2022-12-31¥314.2bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥4.6bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentsegment profit2022-04-01 → 2022-12-31¥30.8bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue2022-04-01 → 2022-12-31¥70.3bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue external2022-04-01 → 2022-12-31¥53.6bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥16.8bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.2bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue2022-04-01 → 2022-12-31¥42.6bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue external2022-04-01 → 2022-12-31¥38.0bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥4.6bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.5bn
—segment totalrevenue2022-04-01 → 2022-12-31¥431.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥405.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥25.9bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥35.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥434.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥406.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥28.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥35.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-12-31¥1.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-12-31¥446m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-12-31¥1.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-12-31¥258m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥26.6bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥26.6bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥20.2bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue2021-04-01 → 2021-12-31¥284.8bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue external2021-04-01 → 2021-12-31¥280.0bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥4.8bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentsegment profit2021-04-01 → 2021-12-31¥31.0bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue2021-04-01 → 2021-12-31¥70.1bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue external2021-04-01 → 2021-12-31¥54.4bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥15.7bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentsegment profit2021-04-01 → 2021-12-31¥6.1bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue2021-04-01 → 2021-12-31¥39.1bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue external2021-04-01 → 2021-12-31¥34.5bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥4.6bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentsegment profit2021-04-01 → 2021-12-31¥2.5bn
—segment totalrevenue2021-04-01 → 2021-12-31¥394.1bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥368.9bn
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥25.1bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥39.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥396.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥369.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥26.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥39.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 449
ItemContextValueUnit
Other net ppeCurrentQuarterInstant24688000000JPY
Property plant and equipmentPrior1YearInstant377752000000JPY
Property plant and equipmentCurrentQuarterInstant422992000000JPY
GoodwillPrior1YearInstant15060000000JPY
GoodwillCurrentQuarterInstant15932000000JPY
Lease assets iaPrior1YearInstant2905000000JPY
Lease assets iaCurrentQuarterInstant2376000000JPY
Other iaPrior1YearInstant14844000000JPY
Other iaCurrentQuarterInstant18027000000JPY
Intangible assetsPrior1YearInstant32810000000JPY
Intangible assetsCurrentQuarterInstant36336000000JPY
Investment securitiesPrior1YearInstant45008000000JPY
Investment securitiesCurrentQuarterInstant39451000000JPY
Net defined benefit assetPrior1YearInstant－JPY
Net defined benefit assetCurrentQuarterInstant85000000JPY
Deferred tax assetsPrior1YearInstant12393000000JPY
Deferred tax assetsCurrentQuarterInstant13323000000JPY
Other ioaPrior1YearInstant31052000000JPY
Other ioaCurrentQuarterInstant30665000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-6154000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-5452000000JPY
Investments and other assetsPrior1YearInstant82299000000JPY
Investments and other assetsCurrentQuarterInstant78073000000JPY
Noncurrent assetsPrior1YearInstant492862000000JPY
Noncurrent assetsCurrentQuarterInstant537402000000JPY
AssetsPrior1YearInstant930321000000JPY
AssetsCurrentQuarterInstant1049221000000JPY
Notes and accounts payable tradePrior1YearInstant73544000000JPY
Notes and accounts payable tradeCurrentQuarterInstant85644000000JPY
Short term loans payablePrior1YearInstant150675000000JPY
Short term loans payableCurrentQuarterInstant159631000000JPY
Commercial papers liabilitiesPrior1YearInstant－JPY
Commercial papers liabilitiesCurrentQuarterInstant10000000000JPY
Current portion of bondsPrior1YearInstant2200000000JPY
Current portion of bondsCurrentQuarterInstant2100000000JPY
Lease obligations clPrior1YearInstant3885000000JPY
Lease obligations clCurrentQuarterInstant4277000000JPY
Accounts payable otherPrior1YearInstant24601000000JPY
Accounts payable otherCurrentQuarterInstant23394000000JPY
Income taxes payablePrior1YearInstant5528000000JPY
Income taxes payableCurrentQuarterInstant3324000000JPY
Advances receivedPrior1YearInstant2115000000JPY
Advances receivedCurrentQuarterInstant441000000JPY
Unearned revenuePrior1YearInstant284000000JPY
Unearned revenueCurrentQuarterInstant326000000JPY
Provision for bonusesPrior1YearInstant5239000000JPY
Provision for bonusesCurrentQuarterInstant6970000000JPY
Provision for directors bonusesPrior1YearInstant166000000JPY
Provision for directors bonusesCurrentQuarterInstant3000000JPY
Provision for loss on disaster clPrior1YearInstant130000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass